Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026
Lifecore Biomedical announced holders submitted notices to redeem all 49,263 shares of its Series A preferred, creating a roughly $52.1 million redemption obligation due December 28, 2026.Key Highlights:Original SEC Filing: LIFECORE BIOMEDICAL, INC. \DE\ [ LFCR ] - 8-K - Jul. 02, 2026This is an AI…